Log in

Articles by Steve Anderson

Steve Anderson
Steve Anderson

Steve Anderson has been writing professionally for the last 15 years. His background in financial writing covers a wide range of sub-sectors; he's covered consumer tech, communications technology, banking products, mobile payments, and many other fields giving him perspective into markets from retail to tech to pharmaceutical and beyond. Contact Steve Anderson via email at [email protected]

Novavax (NASDAQ:NVAX) Makes New Gains as Coronavirus Vaccine Advances
Novavax (NASDAQ:NVAX) Makes New Gains as Coronavirus Vaccine Advances
September 25th, 2020  1:00 AM

While we've seen some of the greats hit that Phase 3 testing position, now there's one more to hit that high ceiling, and it's Novavax (NASDAQ: NVAX).

BioXCel Therapeutics (NASDAQ:BTAI) A Hot Buy That Confuses Analysts
BioXCel Therapeutics (NASDAQ:BTAI) A Hot Buy That Confuses Analysts
September 23rd, 2020  5:00 AM

One big new area for healthcare is the use of artificial intelligence (AI), and BioXCel Therapeutics (NASDAQ:BTAI) is a growing force within this growing market.

Nikola Shakeup at the Top: Executive Chairman Departs Company
Nikola Shakeup at the Top: Executive Chairman Departs Company
September 21st, 2020  1:00 AM

Nikola (NASDAQ:NKLA) made those tough choices today as its executive chairman Trevor Milton announced he'd step down from his current positions within Nikola.

Gilead Sciences (NASDAQ:GILD) Expands its Focus Beyond Covid
Gilead Sciences (NASDAQ:GILD) Expands its Focus Beyond Covid
September 17th, 2020  1:00 AM

The race to a vaccine for the novel coronavirus that shut down so much of the nation and left us all a little bit more wary than we were this time last year is tightening up, and Gilead Sciences (NASDAQ:GILD) isn't exactly at the front of the pack right now.

New Deals Make DraftKings (NASDAQ:DKNG) Better Bet Than Ever
New Deals Make DraftKings (NASDAQ:DKNG) Better Bet Than Ever
September 16th, 2020  1:00 AM

With sports starting to come back into play, however, and a slug of pent-up demand ready to break loose, sports betting operations like DraftKings (NASDAQ:DKNG) suddenly make much more sense

Plug Power Inc. (NASDAQ:PLUG) Has the Drive to Carry On
Plug Power Inc. (NASDAQ:PLUG) Has the Drive to Carry On
September 15th, 2020  1:00 AM

That's led to an advance in electric cars, and even in cars powered by burning hydrogen. Right now, one of the leaders in the hydrogen fuel cell market is Plug Power Inc. (NASDAQ:PLUG)

FireEye (NASDAQ:FEYE) A Risky Proposition in a Field Built on Risk
FireEye (NASDAQ:FEYE) A Risky Proposition in a Field Built on Risk
September 14th, 2020  1:00 AM

One such example is FireEye Inc (NASDAQ:FEYE), which has quite a bit going for it, but with some downsides as well.

Gilead Sciences
Gilead Sciences' (NASDAQ:GILD) Best Value is Still in the Future
September 11th, 2020  1:00 AM

A couple months ago, we took a look at Gilead Sciences (NASDAQ:GILD), whose leading product was a treatment for coronavirus known as remdesivir.

Quest Diagnostics (NYSE:DGX) Improves Its Standing After Earnings
Quest Diagnostics (NYSE:DGX) Improves Its Standing After Earnings
September 10th, 2020  1:00 AM

Quest Diagnostics (NYSE:DGX) demonstrated as much recently, climbing up out of a hole to achieve, if only for a while, new heights in its share price before making something of a return to normalcy.

Sherwin-Williams (NYSE:SHW) Gets a Fresh Coat of Analyst Love
Sherwin-Williams (NYSE:SHW) Gets a Fresh Coat of Analyst Love
September 10th, 2020  1:00 AM

We've seen a lot of great things out of Sherwin-Williams (NYSE:SHW) before, and we're starting to see a fresh crop of great things emerge.

Intel (NASDAQ:INTC) Starting to Look Like a Smart Buy
Intel (NASDAQ:INTC) Starting to Look Like a Smart Buy
September 9th, 2020  1:00 AM

The effect has been seen out at Intel (NASDAQ: INTC), but nowhere near as pronounced as investors liked to hope. There were signs of the company getting its pre-COVID-19 share price

Beyond Meat (NASDAQ:BYND) Still a Tasty Opportunity
Beyond Meat (NASDAQ:BYND) Still a Tasty Opportunity
September 8th, 2020  1:00 AM

It would be easy to look at the market as it sits right now and think that putting money on Beyond Meat (NASDAQ:BYND) is like mortgaging your house to buy Bitcoin at $19,000.

Potential Wins at Inovio Pharmaceuticals (NASDAQ: INO)
Potential Wins at Inovio Pharmaceuticals (NASDAQ: INO)
September 4th, 2020  4:00 AM

When we talked about Inovio Pharmaceuticals (NASDAQ:INO) about a month ago, things weren't exactly looking good for the company.

Fiserv (NASDAQ:FISV) A Name You May Not Know, But Should
Fiserv (NASDAQ:FISV) A Name You May Not Know, But Should
September 3rd, 2020  1:00 AM

One such company is Fiserv (NASDAQ: FISV), whose recent numbers and analysis around it suggest that it's a company poised for some terrific gains to come.

RH
RH's (NYSE:RH) Gains, Market Conditions, Make It Increasingly Attractive
September 2nd, 2020  6:30 AM

No matter how you may feel about RH, formerly Restoration Hardware (NYSE:RH), it's made a lot of significant moves in the last several months.

Corbus Pharmaceuticals (NASDAQ: CRBP) Gives a Bold Buy Signal
Corbus Pharmaceuticals (NASDAQ: CRBP) Gives a Bold Buy Signal
September 1st, 2020  5:45 AM

That's the proposition you get with Corbus Pharmaceuticals (NASDAQ: CRBP), a company which has made some impressive gains, but took one doozy of a ride to get there.

Microsoft (NASDAQ:MSFT) Facing Challenges Ahead
Microsoft (NASDAQ:MSFT) Facing Challenges Ahead
August 31st, 2020  1:00 AM

Microsoft (NASDAQ:MSFT) is a global juggernaut that should be above make-or-break cycles. The notion that Microsoft could face breaking at all might sound casually ludicrous to some,

Sorrento Therapeutics (NASDAQ: SRNE) Short Sellers Likely Will Be Disappointed
Sorrento Therapeutics (NASDAQ: SRNE) Short Sellers Likely Will Be Disappointed
August 31st, 2020  1:00 AM

We've seen explosive growth come out of it since the depths of April's disaster, and Sorrento Therapeutics (NASDAQ: SRNE) has recently emerged as one of the biggest gainers in the field.

Digital Turbine (NASDAQ:APPS) A Highly Volatile Buy
Digital Turbine (NASDAQ:APPS) A Highly Volatile Buy
August 28th, 2020  5:10 AM

One company that's seen some staggering gains—and a few less-staggering losses—is Digital Turbine (NASDAQ: APPS), a company that's delivered a lot of value, but not without some hiccups along the way.

NetApp (NASDAQ:NTAP) Emerges From Economic Disaster With Brand New Focus
NetApp (NASDAQ:NTAP) Emerges From Economic Disaster With Brand New Focus
August 27th, 2020  1:00 AM

that seems to be what happened at NetApp (NASDAQ:NTAP) recently, as despite the top-notch quarter the company just turned in, it's staging massive layoffs nonetheless.

Qorvo (NASDAQ:QRVO) Will Be One Wild Buy
Qorvo (NASDAQ:QRVO) Will Be One Wild Buy
August 27th, 2020  1:00 AM

That's just what's going on with Qorvo (NASDAQ:QRVO), which is turning in big expectations in pretty much every direction simultaneously.

Best Buy (BBY) Proves to be a Best Buy For the Risk-Averse
Best Buy (BBY) Proves to be a Best Buy For the Risk-Averse
August 25th, 2020  1:00 AM

Best Buy (NYSE:BBY) may be a physical retail stock in an increasingly online shopping world, and a big-box retailer at that, but it's increasingly demonstrating that it's got its investors' fortunes in mind.

AstraZeneca Still a Buy as Its Coronavirus Vaccine Looks at a Fast Track
AstraZeneca Still a Buy as Its Coronavirus Vaccine Looks at a Fast Track
August 24th, 2020  1:00 AM

AstraZeneca (LON:AZN) path in recent weeks has been comparatively quiet, and for a company we've cited in the past for its sheer stability, that's probably to be expected.

How Tesla (NASDAQ:TSLA) Can Keep The Streak Alive Into its Stock Split
How Tesla (NASDAQ:TSLA) Can Keep The Streak Alive Into its Stock Split
August 21st, 2020  1:00 AM

The minds, and fevered imaginings of investors, have been captivated by Tesla (NASDAQ:TSLA) stock for the last few months now, as it's made its meteoric rise into $2,000 a share territory.

Estee Lauder (NYSE:EL) Suffers Second Quarter Setbacks, Plans Aggressive Recovery
Estee Lauder (NYSE:EL) Suffers Second Quarter Setbacks, Plans Aggressive Recovery
August 20th, 2020  1:00 AM

It was a bad quarter for Estee Lauder (NYSE:EL). About the only good thing, you could say for it was that revenue turned out to be what was expected, but there's not much else in the way of good news

Momenta Pharmaceuticals (NASDAQ:MNTA) In Huge Deal With Johnson & Johnson (NYSE:JNJ)
Momenta Pharmaceuticals (NASDAQ:MNTA) In Huge Deal With Johnson & Johnson (NYSE:JNJ)
August 19th, 2020  1:00 AM

A move to pursue autoimmune diseases, meanwhile, recently made its own entrance as Johnson & Johnson (NYSE:JNJ) agreed to buy Momenta Pharmaceuticals (NASDAQ:MNTA) for a hefty $6.5 billion.

Kohl
Kohl's (NYSE:KSS) Second Quarter Proves Its Resilience
August 18th, 2020  1:00 AM

The good news is that Kohl's beat estimates across the spectrum. While Wall Street analysts expected the company to lose $0.83 per share, Kohl's came back with losses of just $0.25.

Teladoc Health (TDOC) an Even Better Buy As Credit Suisse Upgrades
Teladoc Health (TDOC) an Even Better Buy As Credit Suisse Upgrades
August 17th, 2020  1:00 AM

Teladoc Health (NYSE:TDOC) increasingly seems to be one of those firms, and it recently picked up one more reason to pay attention: a ranking upgrade at Credit Suisse.

Dillard
Dillard's (NYSE: DDS) Stock Still a Buy Thanks to Cost Containment
August 14th, 2020  1:00 AM

Just over a week ago, we pointed out that Dillard's (NYSE:DDS) was a bargain buy thanks in part to diminished expectations for a retailer in the second quarter of 2020.

Buy in on Simon Property Group (NYSE:SPG) and its Own Buying Spree
Buy in on Simon Property Group (NYSE:SPG) and its Own Buying Spree
August 13th, 2020  1:00 AM

Simon Property Group (NYSE:SPG) is perhaps the biggest example of this, as new reports put it in an acquisitive mood.

Tempted by Inovio Pharmaceuticals (NASDAQ:INO)?
Tempted by Inovio Pharmaceuticals (NASDAQ:INO)?
August 11th, 2020  1:00 AM

It would be easy to be tempted by Inovio Pharmaceuticals (NASDAQ:INO) , a little biotech company out of Pennsylvania that's part of the seemingly endless fray to produce a coronavirus vaccine.

Barrick Gold (NYSE:GOLD): A Buying Opportunity For All Economic Conditions
Barrick Gold (NYSE:GOLD): A Buying Opportunity For All Economic Conditions
August 10th, 2020  1:00 AM

For Barrick Gold (NYSE:GOLD), however, it's delivered some impressive results through what may be the worst period of the US economy ever,

Zillow (NASDAQ:ZG) Still A Buy As Real Estate Gains Big
Zillow (NASDAQ:ZG) Still A Buy As Real Estate Gains Big
August 7th, 2020  1:00 AM

That's not the case at Zillow (NASDAQ:ZG), where the company posted a loss, but still managed to beat estimates and make itself look like a buy, at least in the near-term.

Restaurant Brands (NYSE:QSR) Making a Comeback in Crowded Market
Restaurant Brands (NYSE:QSR) Making a Comeback in Crowded Market
August 6th, 2020  1:00 AM

Restaurant Brands (NYSE:QSR), the parent brand of several major franchise names, recently reported its earnings; though it turned in some positive numbers, and beat expectations, it shows us just how bad things were this quarter.

Activision Blizzard (NASDAQ:ATVI) Makes Gains, Rolls Out Exciting 3Q Forecast
Activision Blizzard (NASDAQ:ATVI) Makes Gains, Rolls Out Exciting 3Q Forecast
August 5th, 2020  1:00 AM

Video games were no different here, and Activision Blizzard (NASDAQ:ATVI) turned in a second-quarter well beyond expectations.

Huge Gains for Regeneron (NASDAQ:REGN) As New Covid Drug Cocktail Hits Late-Stage
Huge Gains for Regeneron (NASDAQ:REGN) As New Covid Drug Cocktail Hits Late-Stage
August 4th, 2020  1:00 AM

One of the latest names on the list in the race for a cure is Regeneron Pharmaceuticals (NASDAQ:REGN), and it's made a major leap forward not on the vaccine front, but on the treatment front instead.

Eli Lilly (NYSE:LLY) Readies New Coronavirus Drug for Testing in Nursing Homes
Eli Lilly (NYSE:LLY) Readies New Coronavirus Drug for Testing in Nursing Homes
August 3rd, 2020  1:00 AM

Eli Lilly (NYSE: LLY) recently revealed it was moving into late-stage testing on a new coronavirus treatment specifically geared toward nursing home patients.

Good Time to Get in on Earnings-Winner Merck (NYSE: MRK)
Good Time to Get in on Earnings-Winner Merck (NYSE: MRK)
July 31st, 2020  1:00 AM

Gains with much less fanfare but no less solid results; gains like those seen recently from Merck (NYSE: MRK), which turned out to be solid if a bit unremarkable, much like the company itself.

New Price Targets on Shopify (NYSE:SHOP) Hit After Winning Quarter
New Price Targets on Shopify (NYSE:SHOP) Hit After Winning Quarter
July 30th, 2020  1:00 AM

There's no doubt that Shopify (NYSE: SHOP) had a fantastic second quarter. Given what happened in the second quarter, and the degree of difficulty for the business that that represented,

Eastman Kodak (NYSE:KODK) Develops Monster Comeback With New Fed Loans
Eastman Kodak (NYSE:KODK) Develops Monster Comeback With New Fed Loans
July 29th, 2020  1:00 AM

Up until about two days ago, Eastman Kodak (NYSE: KODK) looked like one of the biggest dogs the stock market had ever known. It was trading in a woefully steady pattern, and not doing much of anything.

Moderna (NASDAQ: MRNA) Makes Gains on Phase 3 Testing
Moderna (NASDAQ: MRNA) Makes Gains on Phase 3 Testing
July 27th, 2020  1:00 AM

Moderna (NASDAQ: MRNA) has been one of the front-runners for a while now and recently saw some gains on the strength of several new developments.

AstraZeneca (LON:AZN) Follows Up its COVID-19 Progress to Take on an Even Bigger Killer
AstraZeneca (LON:AZN) Follows Up its COVID-19 Progress to Take on an Even Bigger Killer
July 24th, 2020  1:00 AM

It's only been a couple of days since we last talked about AstraZeneca (LON: AZN), but some recently-emerged news around the company makes it worth another look.

PulteGroup (NYSE:PHM) is a Homebuilder Beating the Odds
PulteGroup (NYSE:PHM) is a Homebuilder Beating the Odds
July 23rd, 2020  1:00 AM

PulteGroup (NYSE: PHM), a nationwide homebuilder, saw some impressive gains as it beat estimates on several fronts, ranging from earnings per share to quarterly earnings to even overall revenue.

Pfizer (PFE), BioNTech BNTX) Land Multi-Billion Dollar Order for Vaccine
Pfizer (PFE), BioNTech BNTX) Land Multi-Billion Dollar Order for Vaccine
July 22nd, 2020  1:00 AM

Just announced, the US government has agreed to buy 100 million doses of Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) coronavirus vaccine.

AstraZeneca
AstraZeneca's (LON:AZN) Results Disappoint, Resiliency Makes it Worth a Buy
July 21st, 2020  1:00 AM

AstraZeneca (LON: AZN) has had a bit of an uptick in its share price thanks to some recent news about its work toward a COVID-19 vaccine. While the news has soured a bit

Hang on to Nikola (NASDAQ: NKLA), Get Ready to Buy In Later
Hang on to Nikola (NASDAQ: NKLA), Get Ready to Buy In Later
July 20th, 2020  1:00 AM

Nikola (NASDAQ: NKLA) has made a name for itself by trying to be Tesla's (NASDAQ: TSLA) nemesis. It's gone so far as to complete the bridge in naming;

Netflix (NASDAQ: NFLX) Looks Like a Sell as Conditions Shift
Netflix (NASDAQ: NFLX) Looks Like a Sell as Conditions Shift
July 17th, 2020  1:00 AM

As investors gathered to see just what the numbers looked like out of Netflix's second quarter, the answer increasingly looked like “not a chance.”

Retail Recovery Carries On for Second Straight Month
Retail Recovery Carries On for Second Straight Month
July 16th, 2020  1:00 AM

along with the rest of the pent-up demand, gave retail sales another bump in June of 7.5%, which is actually 1.1% higher than it was this time last June. It was also about 50% better than what Reuters economists were offering as a consensus, at 5% gains.

The Gap (NYSE: GPS) Gets Upgraded and Makes Its Case as a Buy
The Gap (NYSE: GPS) Gets Upgraded and Makes Its Case as a Buy
July 15th, 2020  1:00 AM

For proof, look nowhere else than the Gap (NYSE: GPS), which is making its most powerful case yet as a stock to add to your portfolio.

HanesBrands (HBI) Keeps Improving its Fit, Looks Like a Solid Buy
HanesBrands (HBI) Keeps Improving its Fit, Looks Like a Solid Buy
July 14th, 2020  1:00 AM

If you're looking for a little more comfort in your portfolio, buying HanesBrands stock might be just the thing.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.